$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

$nhhs Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000150370717000011 Filed on May 12, 2017

Income Statement

Concept	2017 Q2	2017 Q1	2016 Q1
Revenue	$68.59M	$37.12M	$48.79M
YoY Change	0.83%	-23.91%	331.17%
Cost Of Revenue	$38.23M
YoY Change
Gross Profit	$30.36M
YoY Change
Gross Profit Margin	44.26%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$19.85M	$24.92M	$11.82M
YoY Change	47.82%	110.76%	601.66%
% of Gross Profit	65.39%
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$14.76M	$14.03M	$8.483M
YoY Change	13.19%	65.37%	415.06%
% of Operating Profit
Other Income/Expense, Net		$28.00K
YoY Change
Pretax Income	-$14.49M	-$21.39M	-$17.25M
YoY Change	38.82%	23.99%	874.8%
Income Tax	$15.00K	$26.00K	$7.100M
% Of Pretax Income
Net Earnings	-$21.59M	-$27.08M	-$38.30M
YoY Change	-22.52%	-29.29%	663.8%
Net Earnings / Revenue	-31.48%	-72.95%	-78.5%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	186.0M shares	185.9M shares	180.7M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q2	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$135.6M	$160.4M	$179.2M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$22.11M	$22.11M	$22.11M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$345.9M	$355.8M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$2.942B	$2.985B	$2.607B
YoY Change	14.75%	14.49%	131.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$1.844B	$1.843B	$1.256B
YoY Change	46.85%	46.82%	557.83%
SHAREHOLDERS EQUITY
Retained Earnings	-$591.4M	-$538.5M	-$284.6M
YoY Change	72.44%	89.19%	314.69%
Common Stock	$1.683B	$1.676B	$1.631B
YoY Change	2.29%	2.81%	62.91%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.092B	$1.136B	$1.346B
YoY Change
Total Liabilities & Shareholders Equity	$2.942B	$2.985B	$2.607B
YoY Change	14.75%	14.49%	131.85%

Cashflow Statement

Concept	2017 Q2	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	-$21.59M	-$27.08M	-$38.30M
YoY Change	-22.52%	-29.29%	663.8%
Depreciation, Depletion And Amortization	$19.85M	$24.92M	$11.82M
YoY Change	47.82%	110.76%	601.66%
Cash From Operating Activities		$2.986M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities		-$2.634M	$0.00
YoY Change			-100.0%
Cash From Investing Activities		-$116.7M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$8.603M	$2.265M
YoY Change		279.82%	-101.84%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$48.69M
YoY Change
NET CHANGE
Cash From Operating Activities		$2.986M
Cash From Investing Activities		-$116.7M
Cash From Financing Activities		$48.69M
Net Change In Cash		-$65.04M
YoY Change
FREE CASH FLOW
Cash From Operating Activities		$2.986M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001503707
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	186026394	shares
CY2017Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2017Q1	dei	Entity Number Of Employees EntityNumberOfEmployees	0	employee
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	NorthStar Healthcare Income, Inc.
CY2017Q1	nshi	Acquisition Feeand Expense Cap AcquisitionFeeandExpenseCap	0.06
CY2017Q1	nshi	Business Acquisition Numberof Properties BusinessAcquisitionNumberofProperties	6	property
CY2017Q1	nshi	Business Combination Consideration Transferred Including Other Deferred Costsand Equity Interestin Acquiree Held Priorto Combination BusinessCombinationConsiderationTransferredIncludingOtherDeferredCostsandEquityInterestinAcquireeHeldPriortoCombination	118865000	USD
CY2017Q1	nshi	Common Stock Annualized Distribution CommonStockAnnualizedDistribution	0.675
CY2017Q1	nshi	Common Stock Dividend Declared Based On Daily Amount Per Share CommonStockDividendDeclaredBasedOnDailyAmountPerShare	0.00184932
CY2017Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	339000	USD
CY2016Q4	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	116404000	USD
CY2017Q1	nshi	Deferred Costs And Intangible Assets Net DeferredCostsAndIntangibleAssetsNet	106899000	USD
CY2016Q1	nshi	Distributions Payable DistributionsPayable	10329000	USD
CY2017Q1	nshi	Distributions Payable DistributionsPayable	10660000	USD
CY2016Q1	nshi	Equity Method Investment Depreciation Amortizationand Transaction Costs EquityMethodInvestmentDepreciationAmortizationandTransactionCosts	22169000	USD
CY2017Q1	nshi	Equity Method Investment Depreciation Amortizationand Transaction Costs EquityMethodInvestmentDepreciationAmortizationandTransactionCosts	10759000	USD
CY2017Q1	nshi	Equity Method Investment Numberof Facilities EquityMethodInvestmentNumberofFacilities	588	facility
CY2016	nshi	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Asset Paydownsand Distributions FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetPaydownsandDistributions	654000	USD
CY2017Q1	nshi	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Asset Paydownsand Distributions FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisAssetPaydownsandDistributions	1034000	USD
CY2016	nshi	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Paydownsand Distributions FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPaydownsandDistributions	654000	USD
CY2017Q1	nshi	Fair Value Measurementwith Unobservable Inputs Reconciliation Recurring Basis Liability Paydownsand Distributions FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisLiabilityPaydownsandDistributions	1034000	USD
CY2015Q1	nshi	Followon Public Offering FollowonPublicOffering	700000000.0	USD
CY2016Q1	nshi	Increase Decreasein Escrow Payable IncreaseDecreaseinEscrowPayable	521000	USD
CY2017Q1	nshi	Lessor Leasing Arrangements Numberof Leases Amended LessorLeasingArrangementsNumberofLeasesAmended	2	lease
CY2016Q4	nshi	Mortgage Loans Heldin Trustat Fair Value MortgageLoansHeldinTrustatFairValue	522933000	USD
CY2017Q1	nshi	Mortgage Loans Heldin Trustat Fair Value MortgageLoansHeldinTrustatFairValue	520666000	USD
CY2016Q4	nshi	Mortgage Loanson Real Estate Heldin Trustat Fair Value MortgageLoansonRealEstateHeldinTrustatFairValue	553707000	USD
CY2017Q1	nshi	Mortgage Loanson Real Estate Heldin Trustat Fair Value MortgageLoansonRealEstateHeldinTrustatFairValue	551806000	USD
CY2016Q1	nshi	Noncash Consolidation Variable Interest Entity NoncashConsolidationVariableInterestEntity	0	USD
CY2017Q1	nshi	Noncash Consolidation Variable Interest Entity NoncashConsolidationVariableInterestEntity	2268000	USD
CY2016Q1	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Seller Financing Amount NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSellerFinancingAmount	0	USD
CY2017Q1	nshi	Noncashor Part Noncash Acquisition Noncash Financialor Equity Instrument Consideration Seller Financing Amount NoncashorPartNoncashAcquisitionNoncashFinancialorEquityInstrumentConsiderationSellerFinancingAmount	3500000	USD
CY2016Q1	nshi	Noncashor Part Noncash Acquisition Valueof Working Capital Acquired NoncashorPartNoncashAcquisitionValueofWorkingCapitalAcquired	2437000	USD
CY2017Q1	nshi	Noncashor Part Noncash Acquisition Valueof Working Capital Acquired NoncashorPartNoncashAcquisitionValueofWorkingCapitalAcquired	0	USD
CY2016Q1	nshi	Noncashor Part Noncash Transaction Noncontrolling Interest Reallocationof Interestin Partnership NoncashorPartNoncashTransactionNoncontrollingInterestReallocationofInterestinPartnership	103005000	USD
CY2017Q1	nshi	Noncashor Part Noncash Transaction Noncontrolling Interest Reallocationof Interestin Partnership NoncashorPartNoncashTransactionNoncontrollingInterestReallocationofInterestinPartnership	0	USD
CY2017Q1	nshi	Number Of Days Past Due For Suspension Of Income Recognition NumberOfDaysPastDueForSuspensionOfIncomeRecognition	P90D
CY2017Q1	nshi	Numberof Days Past Contractual Debt Service Payments Loan Categorizedasa Weaker Credit Quality Debt Investment NumberofDaysPastContractualDebtServicePaymentsLoanCategorizedasaWeakerCreditQualityDebtInvestment	P90D
CY2016Q1	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	0	USD
CY2017Q1	nshi	Other Expense Securitization Trust OtherExpenseSecuritizationTrust	976000	USD
CY2016Q4	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	4554000	USD
CY2017Q1	nshi	Ownership Interestin Condominiums OwnershipInterestinCondominiums	3999000	USD
CY2016Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	5182000	USD
CY2017Q1	nshi	Paymentsto Improve Real Estate PaymentstoImproveRealEstate	2626000	USD
CY2017Q1	nshi	Percentof Interest Income Contributedby Investment PercentofInterestIncomeContributedbyInvestment	0.1
CY2016Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	5639000	USD
CY2017Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Financing Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsFinancingActivities	3739000	USD
CY2016Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Operating Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsOperatingActivities	0	USD
CY2017Q1	nshi	Proceedsfrom Equity Method Investment Dividendsor Distributions Operating Activities ProceedsfromEquityMethodInvestmentDividendsorDistributionsOperatingActivities	179000	USD
CY2017Q1	nshi	Related Party Transaction Dueto Related Parties Amount Incurred RelatedPartyTransactionDuetoRelatedPartiesAmountIncurred	13704000	USD
CY2017Q1	nshi	Related Party Transaction Dueto Related Parties Amount Paid RelatedPartyTransactionDuetoRelatedPartiesAmountPaid	13148000	USD
CY2017Q1	nshi	Share Repurchase Program Holding Period Of Shares Required For Repurchase ShareRepurchaseProgramHoldingPeriodOfSharesRequiredForRepurchase	P1Y
CY2017Q1	nshi	Stock Repurchase Program Unfulfilled Requests StockRepurchaseProgramUnfulfilledRequests	0	USD
CY2016Q1	nshi	Variable Interest Entity Consolidated Liabilities Unrealized Gain Loss VariableInterestEntityConsolidatedLiabilitiesUnrealizedGainLoss	0	USD
CY2017Q1	nshi	Variable Interest Entity Consolidated Liabilities Unrealized Gain Loss VariableInterestEntityConsolidatedLiabilitiesUnrealizedGainLoss	366000	USD
CY2016Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3209000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	25105000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	26183000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	12260000	USD
CY2017Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	14078000	USD
CY2016Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-7000	USD
CY2017Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	22000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1188000	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2209000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1666479000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1674617000	USD
CY2017Q1	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3721000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33800	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	48700	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	588000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	434000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	395000	USD
CY2016Q1	us-gaap	Asset Management Costs AssetManagementCosts	19628000	USD
CY2017Q1	us-gaap	Asset Management Costs AssetManagementCosts	10980000	USD
CY2016Q4	us-gaap	Assets Assets	2958209000	USD
CY2017Q1	us-gaap	Assets Assets	2984658000	USD
CY2017Q1	us-gaap	Assets Fair Value Disclosure Nonrecurring AssetsFairValueDisclosureNonrecurring	0	USD
CY2016Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	200000	USD
CY2017Q1	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1184000	USD
CY2016Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1282000	USD
CY2017Q1	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1018000	USD
CY2017Q1	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	44650000	USD
CY2017Q1	us-gaap	Business Combination Consideration Transferred Liabilities Incurred BusinessCombinationConsiderationTransferredLiabilitiesIncurred	75966000	USD
CY2016Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	6408000	USD
CY2017Q1	us-gaap	Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain	0	USD
CY2016Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	274000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354229000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	179193000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	223102000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	160399000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-175036000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-62703000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.17
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2017Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	185034967	shares
CY2017Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	185933828	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	185034967	shares
CY2017Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	185933828	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1850000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	1859000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-38297000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28100000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-38382000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-28063000	USD
CY2016Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3509000	USD
CY2017Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	3430000	USD
CY2016Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	23397000	USD
CY2017Q1	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	37311000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	72449000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	91734000	USD
CY2016Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	358000	USD
CY2017Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	340000	USD
CY2016Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7026000	USD
CY2017Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7000	USD
CY2017Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	7000	USD
CY2016Q4	us-gaap	Deposit Assets DepositAssets	8710000	USD
CY2017Q1	us-gaap	Deposit Assets DepositAssets	6660000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11823000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24918000	USD
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	9598000	USD
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	10639000	USD
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	10660000	USD
CY2016	us-gaap	Dividends Common Stock DividendsCommonStock	123142000	USD
CY2017Q1	us-gaap	Dividends Common Stock DividendsCommonStock	30897000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4401000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4887000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	4940000	USD
CY2017Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	14228000	USD
CY2017Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5197000	USD
CY2017Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5752000	USD
CY2017Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	5720000	USD
CY2017Q1	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	16669000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10579000	USD
CY2017Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	10660000	USD
CY2016Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	219000	USD
CY2017Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	775000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.15
CY2017Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	509800000	USD
CY2016Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	5640000	USD
CY2017Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	3918000	USD
CY2017Q1	us-gaap	Equity Method Investment Summarized Financial Information Assets EquityMethodInvestmentSummarizedFinancialInformationAssets	6464160000	USD
CY2016Q4	us-gaap	Equity Method Investments EquityMethodInvestments	360534000	USD
CY2017Q1	us-gaap	Equity Method Investments EquityMethodInvestments	355782000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-26057000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-867000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	580418000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	0	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	553707000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	551806000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	26355000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	1233000	USD
CY2016	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	549942000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases	0	USD
CY2015Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	USD
CY2016Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	522933000	USD
CY2017Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	520666000	USD
CY2016Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	0	USD
CY2017Q1	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	366000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	93554000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Asset Acquired In Place Leases FiniteLivedIntangibleAssetAcquiredInPlaceLeases	84067000	USD
CY2016Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	63539000	USD
CY2017Q1	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	64749000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7836000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2503000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	22112000	USD
CY2017Q1	us-gaap	Goodwill Goodwill	22112000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-17254000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-21394000	USD
CY2016Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14037000	USD
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-5622000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7091000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7100000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	114000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1078000	USD
CY2016Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-424000	USD
CY2017Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	556000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1110000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1593000	USD
CY2016Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-82000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	74000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-405000	USD
CY2017Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	1231000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	2548000	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	293000	USD
CY2016Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	2455000	USD
CY2017Q1	us-gaap	Increase Decrease In Restricted Cash For Operating Activities IncreaseDecreaseInRestrictedCashForOperatingActivities	-510000	USD
CY2016Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1329118000	USD
CY2017Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	1425446000	USD
CY2016Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	0	USD
CY2016Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	560000	USD
CY2017Q1	us-gaap	Increase Decrease In Unbilled Receivables IncreaseDecreaseInUnbilledReceivables	530000	USD
CY2016Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	116046000	USD
CY2017Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	106559000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	8483000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	14028000	USD
CY2017Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	4877000	USD
CY2016Q1	us-gaap	Investment Income Net InvestmentIncomeNet	5035000	USD
CY2017Q1	us-gaap	Investment Income Net InvestmentIncomeNet	3501000	USD
CY2016Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	360534000	USD
CY2017Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	355782000	USD
CY2016Q4	us-gaap	Land Land	221353000	USD
CY2017Q1	us-gaap	Land Land	245454000	USD
CY2016Q4	us-gaap	Land Improvements LandImprovements	9462000	USD
CY2017Q1	us-gaap	Land Improvements LandImprovements	9578000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1766235000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	1843489000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2958209000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2984658000	USD
CY2017Q1	us-gaap	Liabilities Fair Value Disclosure Nonrecurring LiabilitiesFairValueDisclosureNonrecurring	0	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	1311889000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1169900000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	61943000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	22794000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	44720000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	10225000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	2307000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	5349000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	5394000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	291000	USD
CY2017Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	56000	USD
CY2016Q4	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	74558000	USD
CY2017Q1	us-gaap	Mortgage Loans On Real Estate Commercial And Consumer Net MortgageLoansOnRealEstateCommercialAndConsumerNet	74580000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-18219000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	50983000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-141797000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-117182000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15020000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	3496000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-85000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	37000	USD
CY2016Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-38297000	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27079000	USD
CY2016Q1	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	648211000	USD
CY2017Q1	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2016	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	291000	USD
CY2017Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	64000	USD
CY2016Q1	us-gaap	Noninterest Income NoninterestIncome	43752000	USD
CY2017Q1	us-gaap	Noninterest Income NoninterestIncome	66445000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	28000	USD
CY2016Q4	us-gaap	Notes Payable NotesPayable	1200982000	USD
CY2017Q1	us-gaap	Notes Payable NotesPayable	1278202000	USD
CY2017Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	segment
CY2017Q1	us-gaap	Number Of Units In Real Estate Property NumberOfUnitsInRealEstateProperty	493	unit
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	43476000	USD
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	65868000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	16874000	USD
CY2017Q1	us-gaap	Other Assets OtherAssets	15803000	USD
CY2016Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1489000	USD
CY2017Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	1551000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1021000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1188000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1021000	USD
CY2016Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2017Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	380000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	3208000	USD
CY2017Q1	us-gaap	Other Liabilities OtherLiabilities	3282000	USD
CY2016Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	276000	USD
CY2017Q1	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	577000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
CY2017Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-2634000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2703000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	8603000	USD
CY2016Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	29908000	USD
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	30816000	USD
CY2016Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	3322000	USD
CY2017Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	765000	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	139618000	USD
CY2017Q1	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	114827000	USD
CY2016Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	28000	USD
CY2017Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	5809000	USD
CY2016Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	USD
CY2017Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	56000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	2114000	USD
CY2017Q1	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	3586000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	1100000000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	438000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	16705000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	16701000	USD
CY2016Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	149000	USD
CY2017Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	64000	USD
CY2016Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	USD
CY2017Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	72466000	USD
CY2016Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	463000	USD
CY2017Q1	us-gaap	Proceeds From Repayments Of Restricted Cash Financing Activities ProceedsFromRepaymentsOfRestrictedCashFinancingActivities	2290000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	-60000	USD
CY2017Q1	us-gaap	Proceeds From Sale And Collection Of Mortgage Notes Receivable ProceedsFromSaleAndCollectionOfMortgageNotesReceivable	0	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-38382000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-141282000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-27042000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	60173000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	74974000	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1632153000	USD
CY2017Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	1753829000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1571980000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1678855000	USD
CY2016Q4	us-gaap	Real Estate Investments RealEstateInvestments	1571980000	USD
CY2017Q1	us-gaap	Real Estate Investments RealEstateInvestments	1678855000	USD
CY2016Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	18435000	USD
CY2017Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	37121000	USD
CY2016Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2017Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	28000	USD
CY2016Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	41000	USD
CY2017Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	298000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	28790000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	26456000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-480516000	USD
CY2017Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-538492000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	34000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	49000	USD
CY2016Q2	us-gaap	Share Price SharePrice	9.10
CY2016	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	67762000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	16701000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	296000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	166000	USD
CY2017Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	49000	USD
CY2016	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	16138000	USD
CY2017Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	8603000	USD
CY2016	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1800000	shares
CY2017Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	900000	shares
CY2016	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	16100000	USD
CY2017Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	8600000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1186625000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1135775000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1405500000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1191974000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1141169000	USD
CY2016Q4	us-gaap	Tenant Improvements TenantImprovements	5172000	USD
CY2017Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.19
CY2017Q1	us-gaap	Tenant Improvements TenantImprovements	5172000	USD
CY2016Q1	us-gaap	Tenant Reimbursements TenantReimbursements	25041000	USD
CY2017Q1	us-gaap	Tenant Reimbursements TenantReimbursements	28747000	USD
CY2016	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	9.15
CY2017Q1	us-gaap	Variable Interest Entity Nonconsolidated Carrying Amount Assets And Liabilities Net VariableInterestEntityNonconsolidatedCarryingAmountAssetsAndLiabilitiesNet	355800000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	180150495	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	185650147	shares
CY2017Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Business and Organization</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">NorthStar Healthcare Income, Inc. (the “Company”) was formed to acquire, originate and asset manage a diversified portfolio of equity, debt and securities investments in healthcare real estate, directly or through joint ventures, with a focus on the mid-acuity senior housing sector, which the Company defines as assisted living (“ALF”), memory care (“MCF”), skilled nursing (“SNF”), independent living (“ILF”) facilities and continuing care retirement communities (“CCRC”), which may have independent living, assisted living, skilled nursing and memory care available on one campus. The Company also invests in other healthcare property types, including medical office buildings (“MOB”), hospitals, rehabilitation facilities and ancillary healthcare services businesses. The Company’s investments are predominantly in the United States, but it also selectively makes international investments. The Company was formed in October 2010 as a Maryland corporation and commenced operations in February 2013. The Company elected to be taxed as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”), commencing with the taxable </font><font style="font-family:inherit;font-size:10pt;">year ended</font><font style="font-family:inherit;font-size:10pt;"> December 31, 2013. The Company conducts its operations so as to continue to qualify as a REIT for U.S. federal income tax purposes.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s equity investments are generally healthcare properties, which are either structured as net leases to healthcare operators or operated through management agreements with independent third-party operators, where applicable through the REIT Investment Diversification and Empowerment Act of 2007 (“RIDEA”) structures that permit the Company, through taxable REIT subsidiaries (“TRS”), to have direct exposure to resident fee income and incur related operating expenses. The Company’s debt investments generally consist of first mortgage loans and mezzanine loans. The Company’s real estate securities investments may include commercial mortgage-backed securities, or CMBS, and other securities backed primarily by loans secured by healthcare properties. Refer to Note 6. “Healthcare-Related Securities” and Note 13. “Segment Reporting” for further discussion.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company is externally managed and has </font><font style="font-family:inherit;font-size:10pt;">no</font><font style="font-family:inherit;font-size:10pt;"> employees. Prior to January 11, 2017, the Company was managed by an affiliate of NorthStar Asset Management Group Inc. (NYSE: NSAM) (“NSAM”). Effective January 10, 2017, NSAM completed its previously announced mergers with Colony Capital, Inc. (“Colony”), NorthStar Realty Finance Corp. (“NorthStar Realty”) and Colony NorthStar, Inc. (“Colony NorthStar”), a wholly-owned subsidiary of NSAM, which the Company refers to as the mergers, with Colony NorthStar surviving the mergers and succeeding NSAM as the Company’s sponsor (the “Sponsor”). As a result of the mergers, the Sponsor became an internally-managed equity REIT, with a diversified real estate and investment management platform and publicly-traded on the NYSE under the ticker symbol “CLNS.” CNI NSHC Advisors, LLC, as successor to NSAM J-NSHC Ltd, or the Advisor, is now a subsidiary of Colony NorthStar. The Advisor manages the Company’s day-to-day operations pursuant to an advisory agreement. The mergers had no material impact on the Company’s operations.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Colony NorthStar manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded REITs and registered investment companies.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> Substantially all of the Company’s business is conducted through NorthStar Healthcare Income Operating Partnership, LP (the “Operating Partnership”). The Company is the sole general partner of the Operating Partnership. The limited partners of the Operating Partnership are NorthStar Healthcare Income Advisor, LLC (the “Prior Advisor”) and NorthStar Healthcare Income OP Holdings, LLC (the “Special Unit Holder”), each an affiliate of the Sponsor. The Prior Advisor invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership in exchange for common units and the Special Unit Holder invested </font><font style="font-family:inherit;font-size:10pt;">$1,000</font><font style="font-family:inherit;font-size:10pt;"> in the Operating Partnership and was issued a separate class of limited partnership units (the “Special Units”), which are collectively recorded as non-controlling interests on the accompanying consolidated balance sheets as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;"> and December 31, </font><font style="font-family:inherit;font-size:10pt;">2016</font><font style="font-family:inherit;font-size:10pt;">. As the Company issued shares, it contributed substantially all of the proceeds from its continuous, public offerings to the Operating Partnership as a capital contribution. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company’s limited partnership interest in the Operating Partnership was </font><font style="font-family:inherit;font-size:10pt;">99.99%</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company’s charter authorizes the issuance of up to </font><font style="font-family:inherit;font-size:10pt;">400.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of common stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share and up to </font><font style="font-family:inherit;font-size:10pt;">50.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares of preferred stock with a par value of </font><font style="font-family:inherit;font-size:10pt;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> per share. The board of directors of the Company is authorized to amend its charter, without the approval of the stockholders, to increase the aggregate number of authorized shares of capital stock or the number of shares of any class or series that the Company has authority to issue.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company initially registered to offer up to </font><font style="font-family:inherit;font-size:10pt;">100.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares pursuant to its primary offering to the public (the “Initial Primary Offering”) and up to </font><font style="font-family:inherit;font-size:10pt;">10.5 million</font><font style="font-family:inherit;font-size:10pt;"> shares pursuant to its distribution reinvestment plan (the “Initial DRP”), which are herein collectively referred to as the Initial Offering. The Initial Offering (including </font><font style="font-family:inherit;font-size:10pt;">8.6 million</font><font style="font-family:inherit;font-size:10pt;"> shares reallocated from the Initial DRP) was completed on </font><font style="font-family:inherit;font-size:10pt;">February 2, 2015</font><font style="font-family:inherit;font-size:10pt;"> by raising gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$1.1 billion</font><font style="font-family:inherit;font-size:10pt;">. All of the shares initially registered for the Initial Offering were issued.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On </font><font style="font-family:inherit;font-size:10pt;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">, the Company’s registration statement on Form S-11 was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) for a follow-on public offering (the “Follow-on Offering”) of up to </font><font style="font-family:inherit;font-size:10pt;">$700.0 million</font><font style="font-family:inherit;font-size:10pt;"> which included up to </font><font style="font-family:inherit;font-size:10pt;">$500.0 million</font><font style="font-family:inherit;font-size:10pt;"> in shares pursuant to its follow-on primary offering (the “Follow-on Primary Offering”) and up to </font><font style="font-family:inherit;font-size:10pt;">$200.0 million</font><font style="font-family:inherit;font-size:10pt;"> in shares pursuant to its follow-on distribution reinvestment plan (the “Follow-on DRP”). The Company stopped accepting subscriptions for the Follow-on Offering on December 17, 2015 and all of the shares initially registered (including </font><font style="font-family:inherit;font-size:10pt;">$159.5 million</font><font style="font-family:inherit;font-size:10pt;"> of shares reallocated from the Follow-on DRP) for the Follow-on Offering were issued on or before January 19, 2016. The Company registered an additional </font><font style="font-family:inherit;font-size:10pt;">30.0 million</font><font style="font-family:inherit;font-size:10pt;"> shares to be offered pursuant to its DRP beyond the completion of the Follow-on Offering and continues to offer such shares.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Initial Primary Offering and the Follow-on Primary Offering are collectively referred to as the Primary Offering and the distribution reinvestment plan, including but not limited to, the Initial DRP and Follow-on DRP, are collectively referred to as the DRP. Additionally, the Primary Offering and the Initial DRP and Follow-on DRP are collectively referred to as the Offering.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company retained NorthStar Securities, LLC (the “Dealer Manager”), formerly a subsidiary of NorthStar Realty that became a subsidiary of NSAM upon completion of the spin-off, to serve as the dealer manager for the Primary Offering.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">From inception through </font><font style="font-family:inherit;font-size:10pt;">May 5, 2017</font><font style="font-family:inherit;font-size:10pt;">, the Company raised total gross proceeds of </font><font style="font-family:inherit;font-size:10pt;">$1.9 billion</font><font style="font-family:inherit;font-size:10pt;">, including </font><font style="font-family:inherit;font-size:10pt;">$154.8 million</font><font style="font-family:inherit;font-size:10pt;"> in DRP proceeds.</font></div></div>
CY2017Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that could affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates and assumptions.</font></div></div>

Files In Submission

Name	View Source	Status
0001503707-17-000011-index-headers.html	Edgar Link	pending
0001503707-17-000011-index.html	Edgar Link	pending
0001503707-17-000011.txt	Edgar Link	pending
0001503707-17-000011-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nshi-0331201710xq.htm	Edgar Link	pending
nshi-03312017xexhibit311.htm	Edgar Link	pending
nshi-03312017xexhibit312.htm	Edgar Link	pending
nshi-03312017xexhibit321.htm	Edgar Link	pending
nshi-03312017xexhibit322.htm	Edgar Link	pending
nshi-20170331.xml	Edgar Link	completed
nshi-20170331.xsd	Edgar Link	pending
nshi-20170331_cal.xml	Edgar Link	unprocessable
nshi-20170331_def.xml	Edgar Link	unprocessable
nshi-20170331_lab.xml	Edgar Link	unprocessable
nshi-20170331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
relocationa06.jpg	Edgar Link	pending
report.css	Edgar Link	pending
repropertytypea05.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs

2017 Q2 Form 10-Q Financial Statement

#000150370717000011 Filed on May 12, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS NorthStar Healthcare Income, Inc. Stock $nhhs

2017 Q2 Form 10-Q Financial Statement

#000150370717000011 Filed on May 12, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHHS
NorthStar Healthcare Income, Inc. Stock $nhhs